- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
The West Nile Test market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of West Nile Virus (WNV), a mosquito-borne virus that can cause serious illness in humans. Tests for WNV are used to diagnose active infections, as well as to monitor for the presence of the virus in the environment. Tests are available in a variety of formats, including ELISA, PCR, and rapid antigen tests.
The West Nile Test market is primarily driven by the need to detect and monitor WNV in order to protect public health. Governments, healthcare providers, and public health organizations are the primary customers for these tests.
Companies in the West Nile Test market include Bio-Rad Laboratories, DiaSorin, GenMark Diagnostics, Luminex Corporation, and Quidel Corporation. Show Less Read more